Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
10 hasil
Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Technical Field of the Invention
This invention relates generally to cytoenzymology, and more particularly to methods and reagents used in cytoenzymology.
2. Discussion of the Background Art
Apoptosis, or programmed cell death, is a process that involves the activation
Nucleic acid encoding modified human tnf.alpha. (tumor necrosis factor alpha) receptor
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to recombinant proteins and their use.
Tumour necrosis factor-.alpha. (TNF.alpha.) is a potent cytokine which elicits a broad spectrum of biological responses. TNF.alpha. causes the cytolysis or cytostasis of many tumour cell lines in vitro, induces the haemorrhagic
Soluble receptor BR43x2
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
Cellular interactions which occur during an immune response are regulated by members of several families of cell surface receptors, including the tumor necrosis factor receptor (TNFR) family. The TNFR family consists of a number of integral membrane glycoprotein receptors
Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
Cellular interactions which occur during an immune response are regulated by members of several families of cell surface receptors, including the tumor necrosis factor receptor (TNFR) family. The TNFR family consists of a number of integral membrane glycoprotein receptors
DNA molecule encoding TNF binding ligands and vectors and host cells containing the DNA molecule
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to ligands to Tumor Necrosis Factor receptors (TNF-Rs) which inhibit the effect of TNF but not its binding to the TNF-Rs, as well as to ligands interacting with other receptors of the TNF/NGF family.
BACKGROUND OF THE INVENTION
Tumor necrosis
TNF ligands
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to ligands to Tumor Necrosis Factor receptors (TNF-Rs) which inhibit the effect of TNF but not its binding to the TNF-Rs, as well as to ligands interacting with other receptors of the TNF/NGF receptor family.
BACKGROUND OF THE INVENTION
Tumor
Compositions and methods for modulating responses mediated or associated with BTLA activity
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
The invention relates to polypeptides that include a binding site for immunoregulatory molecule B-T lymphocyte attenuator (BTLA). Furthermore, the invention relates to ligands, such as antibodies, that bind to a binding site for immunoregulatory molecule B-T lymphocyte attenuator
Method of inhibiting the cytocidal effect of TNF with TNF receptor-specific antibodies
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to ligands to Tumor Necrosis Factor receptors (TNF-Rs) which inhibit the effect of TNF but not its binding to the TNF-Rs, as well as to ligands interacting with other receptors of the TNF/NGF family.
BACKGROUND OF THE INVENTION
Tumor necrosis
TNF receptor-specific antibodies
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to ligands to Tumor Necrosis Factor receptors (TNF-Rs) which inhibit the effect of TNF but not its binding to the TNF-Rs, as well as to ligands interacting with other receptors of the TNF/NGF family.
BACKGROUND OF THE INVENTION
Tumor necrosis
Cyclic, cystein-free protein
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to a cyclic protein free from cysteines which can be used as a medicament, e.g., for activating epithelial ion channels, for improving the lung function as well as for treating oedemas such as pulmonary oedemas.
The fluid transport through cell layers and tissue is
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
